#AbbVie has announced its biggest #acquisition since the $63 billion mega-merger with Allergan in 2020, agreeing to take control of #immunology specialist #ApogeeTherapeutics in a $10.9 billion deal.
AbbVie has announced its biggest acquisition since the $63 billion merger with Allergan, buying Apogee and its 'mega-blockbuster' immunology pipeline.
